Hematopoietic Stem Cell Transplantation in Late ‐Onset Krabbe Disease: No Evidence of Worsening Demyelination and Axonal Loss 4 Years Post‐allograft

CONCLUSIONSClinical evidence and stability of advanced MR measures related to myelin and axons supports HSCT as an effective treatment strategy for stopping progression associated with late‐onset Krabbe disease.

Source: Journal of Neuroimaging - January 1, 2018 Category: Radiology Authors: Cornelia Laule, Irene M. Vavasour, Elham Shahinfard, Burkhard M ädler, Jing Zhang, David K. B. Li, Alex L. MacKay, Sandra M. Sirrs Tags: Short Communication Source Type: research